Diagnostic value of contrast-enhanced ultrasound and shear-wave elastography for small breast nodules
- PMID: 38974410
- PMCID: PMC11227273
- DOI: 10.7717/peerj.17677
Diagnostic value of contrast-enhanced ultrasound and shear-wave elastography for small breast nodules
Abstract
Background: The study aims to evaluate the diagnostic efficacy of contrast-enhanced ultrasound (CEUS) and shear-wave elastography (SWE) in detecting small malignant breast nodules in an effort to inform further refinements of the Breast Imaging Reporting and Data System (BI-RADS) classification system.
Methods: This study retrospectively analyzed patients with breast nodules who underwent conventional ultrasound, CEUS, and SWE at Gongli Hospital from November 2015 to December 2019. The inclusion criteria were nodules ≤ 2 cm in diameter with pathological outcomes determined by biopsy, no prior treatments, and solid or predominantly solid nodules. The exclusion criteria included pregnancy or lactation and low-quality images. Imaging features were detailed and classified per BI-RADS. Diagnostic accuracy was assessed using receiver operating characteristic curves.
Results: The study included 302 patients with 305 breast nodules, 113 of which were malignant. The diagnostic accuracy was significantly improved by combining the BI-RADS classification with CEUS and SWE. The combined approach yielded a sensitivity of 88.5%, specificity of 87.0%, positive predictive value of 80.0%, negative predictive value of 92.8%, and accuracy of 87.5% with an area under the curve of 0.877. Notably, 55.8% of BI-RADS 4A nodules were downgraded to BI-RADS 3 and confirmed as benign after pathological examination, suggesting the potential to avoid unnecessary biopsies.
Conclusion: The integrated use of the BI-RADS classification, CEUS, and SWE enhances the accuracy of differentiating benign and malignant small breast nodule, potentially reducing the need for unnecessary biopsies.
Keywords: BI-RADS classification; Contrast-enhanced ultrasound; Shear-wave elastography; Small breast nodule; Ultrasound.
©2024 Shen et al.
Conflict of interest statement
The authors declare there are no competing interests.
Figures



Similar articles
-
Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses.Eur J Radiol. 2024 Apr;173:111391. doi: 10.1016/j.ejrad.2024.111391. Epub 2024 Feb 28. Eur J Radiol. 2024. PMID: 38422608
-
Evaluating diagnostic significance: The utilization of elastography and contrast-enhanced ultrasound for differential diagnosis in breast lesions.Clin Hemorheol Microcirc. 2024;88(1):81-95. doi: 10.3233/CH-242216. Clin Hemorheol Microcirc. 2024. PMID: 38758994
-
Differential Diagnosis of Breast Category 3 and 4 Nodules Through BI-RADS Classification in Conjunction with Shear Wave Elastography.Ultrasound Med Biol. 2017 Mar;43(3):601-606. doi: 10.1016/j.ultrasmedbio.2016.10.004. Epub 2016 Dec 14. Ultrasound Med Biol. 2017. PMID: 27988221
-
Diagnostic Accuracy of Shear-Wave Elastography for Breast Lesion Characterization in Women: A Systematic Review and Meta-Analysis.J Am Coll Radiol. 2022 May;19(5):625-634.e0. doi: 10.1016/j.jacr.2022.02.022. Epub 2022 Mar 28. J Am Coll Radiol. 2022. PMID: 35358483
-
Value of sonoelastography for diagnosis of breast non-mass lesions and comparison with BI-RADS: A systematic review and meta-analysis.Medicine (Baltimore). 2024 Jun 7;103(23):e38425. doi: 10.1097/MD.0000000000038425. Medicine (Baltimore). 2024. PMID: 38847732 Free PMC article.
Cited by
-
Diagnostic value of mammography combined with ultrasound shear wave elastography and magnetic resonance imaging in breast cancer.Oncol Lett. 2024 Dec 3;29(2):85. doi: 10.3892/ol.2024.14831. eCollection 2025 Feb. Oncol Lett. 2024. PMID: 39664614 Free PMC article.
-
Ultrasound elastography: advances and challenges in early detection of breast cancer.Front Oncol. 2025 Jun 26;15:1589142. doi: 10.3389/fonc.2025.1589142. eCollection 2025. Front Oncol. 2025. PMID: 40641918 Free PMC article. Review.
References
-
- Aouad P, Saikali M, Abdel-Samad R, Fostok S, El-Houjeiri L, Pisano C, Talhouk R, Darwiche N. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models. Anti-Cancer Drugs. 2017;28:757–770. doi: 10.1097/CAD.0000000000000511. - DOI - PubMed
-
- Bonsu AB, Ncama BP. Evidence of promoting prevention and the early detection of breast cancer among women, a hospital-based education and screening interventions in low- and middle-income countries: a systematic review protocol. Systematic Reviews. 2018;7:234. doi: 10.1186/s13643-018-0889-0. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical